Jakob Nadine, Hammerl Jens A, Swierczewski Brett E, Würstle Silvia, Bugert Joachim J
Bundeswehr Institute of Microbiology, Munich, Germany.
German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Virus Genes. 2025 Feb;61(1):132-135. doi: 10.1007/s11262-024-02124-0. Epub 2024 Dec 10.
Adjuvant therapy with bacteriophage (phage) cocktails in combination with antibiotics is a therapeutic approach currently considered for treatment of infections with encapsulated, biofilm forming, and multidrug-resistant Klebsiella pneumoniae (Kp). Klebsiella phage are highly selective in targeting a bacterial capsule type. Considering the numerous Kp capsule types and other host restriction factors, phage treatment could be facilitated when generating phages with a broad host range. A modified 'Appelmans protocol' was used to create phages with an extended host range via in vitro forced DNA recombination. Three T7-like Kp phages with highly colinear genomes were subjected to successive propagation on their susceptible host strains representing the capsule types K64, K27, and K23, and five Kp isolates of the same capsule types initially unsusceptible for phage lysis. After 30 propagation cycles, five phages were isolated via plaque assay. Four output phages represented the original input phages, while the fifth lysed a previously non-permissible Kp isolate, which was not lysed by any of the input phages. Surprisingly, sequence analysis revealed a novel N15/phiKO2-like phage genome (vB_KpnS_KpLi5) lacking substantial homologies to any of the used T7-like phages. This phage is not a chimeric recombinant of the applied T7-like phages, but represents a temperate phage that was induced from Kp due to the application of the input phages phages (cocktail), but not by any of them individually. Adapted phages with chimeric genomes and extended host range derived from input phages were not observed. Induction of temperate phages may be a stress response caused by using multiple phages simultaneously (i.e., by destabilization of the cell wall due to an unspecific binding of the phages). Successive use of different phages for therapeutic purposes may be preferable over simultaneous application in cocktail formulations to avoid undesired induction of temperate phages.
使用噬菌体鸡尾酒联合抗生素进行辅助治疗是目前被认为用于治疗由具有荚膜、形成生物膜且耐多药的肺炎克雷伯菌(Kp)引起的感染的一种治疗方法。克雷伯菌噬菌体在靶向细菌荚膜类型方面具有高度选择性。考虑到众多的Kp荚膜类型和其他宿主限制因素,当产生具有广泛宿主范围的噬菌体时,噬菌体治疗可能会更容易。采用改良的“阿佩尔曼斯方案”通过体外强制DNA重组来创建具有扩展宿主范围的噬菌体。三种基因组高度共线性的T7样Kp噬菌体在分别代表K64、K27和K23荚膜类型的敏感宿主菌株以及最初对噬菌体裂解不敏感的相同荚膜类型的五种Kp分离株上连续传代。经过30个传代周期后,通过噬菌斑测定分离出五种噬菌体。四种输出噬菌体代表原始输入噬菌体,而第五种噬菌体裂解了一种先前不允许被裂解的Kp分离株,该分离株未被任何一种输入噬菌体裂解。令人惊讶的是,序列分析揭示了一种新的N15/phiKO2样噬菌体基因组(vB_KpnS_KpLi5),与任何一种使用的T7样噬菌体均无实质性同源性。这种噬菌体不是所应用的T7样噬菌体的嵌合重组体,而是一种温和噬菌体,它是由于应用输入噬菌体(鸡尾酒)而从Kp中诱导产生的,但不是由其中任何一种单独诱导产生的。未观察到源自输入噬菌体的具有嵌合基因组和扩展宿主范围的适应性噬菌体。温和噬菌体的诱导可能是由于同时使用多种噬菌体(即由于噬菌体的非特异性结合导致细胞壁不稳定)引起的应激反应。为避免意外诱导温和噬菌体,连续使用不同噬菌体进行治疗可能比同时应用于鸡尾酒制剂更可取。